Catalent
CTLT
$43.95
Share price
-1.41%
Change (1 day)
-59.59%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Market capitalization of Catalent (CTLT)
Market cap: $7.92 Billion
As of October 2023 Catalent has a market cap of $7.92 Billion. This makes Catalent the world's 1738th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Catalent from 2014 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $7.92 B | -2.19% |
| 2022 | $8.10 B | -64.65% |
| 2021 | $22.91 B | 33.71% |
| 2020 | $17.14 B | 107.95% |
| 2019 | $8.24 B | 81.53% |
| 2018 | $4.54 B | -16.81% |
| 2017 | $5.45 B | 62.28% |
| 2016 | $3.36 B | 7.91% |
| 2015 | $3.11 B | -9.71% |
| 2014 | $3.45 B |
End of Day market cap according to different sources
On Oct 3rd, 2023 the market cap of Catalent was reported to be:
$8.09 Billion
$8.09 Billion
$7.91 Billion
$7.92 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $1.47 B | -81.33% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | $8.01 B | 1.13% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | $0.75 B | -90.49% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | $0.77 B | -90.17% | 🇺🇸 USA |